Sign up USA
Proactive Investors - Run By Investors For Investors
Markets

NCR lowers guidance after disappointing ATM orders in the third quarter

Also featured: CAI International, Daqo New Energy, NCR Corporation, Supervalu, Skechers USA Inc, Celgene Corporation and Atlassian Corporation
Cash machine
NCR lowered full-year guidance

A look at the day's big movers

RISERS

CAI International Inc (NYSE:CAI), up 17% at US$36.68

Transportation and logistics company CAI was going places in early trades, after it reported net income for the third quarter of US$69.1mln, versus a loss of US$5.5mln the year before.

Daqo New Energy Corp (NYSE:DQ), up 10% at US$36.04

The manufacturer of high-purity poly-silicon for the global solar photo-voltaic industry said its board has officially approved the company's Phase 3B expansion plan for its poly-silicon facilities in Xinjiang.

FALLERS

NCR Corporation (NYSE:NCR), down 11% at US$33.04

The cash dispensing machine maker said orders for automatic telling machines (ATMs) in the third quarter were disappointing, resulting in the company reducing full-year guidance.

Supervalu Inc (NYSE:SVU), down 7% at US$14.60

The wholesale distributor made a net loss of US$25mln in the 12 weeks to 9 September, versus a profit of US$31mln in the corresponding period of last year. It also announced it was buying Associated Grocers of Florida for US$180mln.

 

Pre-market movers

Online payments specialist Paypal Holdings Inc (NASDAQ:PYPL) was wanted in after-hours trading after topping expectations with its earnings.

The firm also raised its outlook for the full year, now expecting revenues in the range of between US$12.92bn and US$12.98bn.

READ Paypal Holdings boosted by growth in mobile as it raises full year outlook

The shares were up almost 4% at US$69.84 in screen-based trading.

That rise was put in the shade by the 27% surge to US$30.45 by Skechers USA Inc (NYSE:SKX), the footwear company.

Third quarter earnings per share of 59 cents were 16 cents higher than the market had been expecting.

“Third quarter net sales of US$1.095 billion set a new quarterly record for the Company, surpassing our previous record in the first quarter earlier this year by $22 million, and resulted in a new nine month record with sales exceeding $3 billion,” said David Weinberg, chief operating officer and chief financial officer of Skechers.

Fiscal first quarter results from collaboration software outfit Atlassian Corporation PLC (NASDAQ:TEAM) sparked a surge in demand for the shares, which rose 12% to US$45.10 in after-hours trading.

Total revenue in the three months to the end of September was US$193.8, up 42% from US$136.8 million for the first quarter of fiscal 2017.

Adjusted net income was US$29.9mln, versus US$22.7mln the year before.

Going the other way was Celgene Corporation (NASDAQ:CELG), the cancer and inflammatory diseases drugs developer.

The shares retreated 5.5% to US$128.50 after the company announced it would not take a possible Crohn’s disease treatment to Phase 3 trial.

READ Celgene stock drops on drug development disappointment

Medtech firm Intuitive Surgical Inc (NASDAQ:ISRG) found the market hard to please.

The shares dipped 3.2% to US$345.90, despite reporting third quarter revenues and profits that beat Wall Street's consensus forecasts.

Net income weighed in at US$323.8mln, equivalent to US$2.77 a share; that was up from US$245.7mln (US$2.06 a share) the year before ans better than the US$1.99 a share analysts had been expecting.

John-H.jpg

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use